KLP Kapitalforvaltning AS Has $12.26 Million Holdings in Agilent Technologies, Inc. $A

Key Points

• KLP Kapitalforvaltning AS increased its stake in Agilent Technologies by 1.8%, now holding $12.26 million worth of shares.
• Agilent Technologies reported a quarterly EPS of $1.37, matching analyst expectations, with year-over-year revenue growth of 10.1%.
• The company recently declared a quarterly dividend of $0.248 per share, with an annualized yield of 0.7%.

KLP Kapitalforvaltning AS increased its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 1.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 103,849 shares of the medical research company's stock after buying an additional 1,800 shares during the quarter. KLP Kapitalforvaltning AS's holdings in Agilent Technologies were worth $12,255,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in A. Generation Investment Management LLP boosted its holdings in shares of Agilent Technologies by 19.8% in the 1st quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company's stock valued at $582,976,000 after buying an additional 824,243 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Agilent Technologies by 18.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company's stock valued at $448,748,000 after buying an additional 604,124 shares during the last quarter. Mackenzie Financial Corp lifted its holdings in Agilent Technologies by 141.5% during the 1st quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company's stock valued at $109,481,000 after purchasing an additional 548,344 shares during the last quarter. Woodline Partners LP lifted its holdings in Agilent Technologies by 681.6% during the 1st quarter. Woodline Partners LP now owns 522,073 shares of the medical research company's stock valued at $61,072,000 after purchasing an additional 455,276 shares during the last quarter. Finally, Parnassus Investments LLC lifted its holdings in Agilent Technologies by 38.3% during the 1st quarter. Parnassus Investments LLC now owns 1,577,999 shares of the medical research company's stock valued at $184,594,000 after purchasing an additional 437,242 shares during the last quarter.

Agilent Technologies Stock Up 1.6%

A stock opened at $140.81 on Thursday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The stock has a market capitalization of $39.92 billion, a price-to-earnings ratio of 33.05, a PEG ratio of 4.52 and a beta of 1.26. The business's fifty day moving average price is $124.07 and its two-hundred day moving average price is $116.81. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting analysts' consensus estimates of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.67 billion. During the same quarter last year, the business earned $1.32 earnings per share. Agilent Technologies's revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be given a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies's dividend payout ratio (DPR) is presently 23.24%.

Analyst Upgrades and Downgrades

A has been the subject of several research reports. Wall Street Zen raised Agilent Technologies from a "hold" rating to a "buy" rating in a report on Friday, October 3rd. Evercore ISI raised their price target on Agilent Technologies from $128.00 to $140.00 and gave the company an "in-line" rating in a report on Tuesday. Wells Fargo & Company raised their price target on Agilent Technologies from $140.00 to $150.00 and gave the company an "overweight" rating in a report on Monday, September 15th. Rothschild & Co Redburn initiated coverage on Agilent Technologies in a report on Wednesday. They set a "buy" rating and a $165.00 price target for the company. Finally, Robert W. Baird increased their price objective on Agilent Technologies from $141.00 to $142.00 and gave the stock an "outperform" rating in a research report on Thursday, August 28th. Eight equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, Agilent Technologies has an average rating of "Moderate Buy" and an average price target of $147.92.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.